Research shows that taking GLP-1 receptor agonists may increase a persons risk of developing certain vision problems, including NAION, which can cause sudden, painless vision loss in one eye due to reduced blood flow in the optic nerve
GLP-1 receptor agonists and DPP4-inhibitor direct the T2DM therapies
Better blood sugar control can help curb cravings for high-calorie, sugary foods, further supporting your weight management goals
Food and Drug Administration warned consumers last year not to use generic versions of Ozempic and Wegovy over concerns they contain semaglutide that has been compounded or mixed in pharmacies and not approved for use in humans
No single mechanism explains all observed effects
Adv Healthc Mater 14:2402376 Nabipour H, Rohani S (2024) Metalorganic frameworks for overcoming the blood-brain barrier in the treatment of brain diseases: a review